ODI receives 7.4 mill NOK in public funding

Oslo 2016-01-01
ODI Medical has been granted 7.4 mill NOK over 2 years from The Research Council of Norway (RCN) under the FORNY2020 program.
 
The granted project is titled: Oxygen Delivery Index – an optical biomarker for bedside diagnosis of circulatory failure
 
ODI will use the grant to further develop its technology for bed-side monitoring of circulatory failure by assessment of microcirculation and to demonstrate its potential in pilot clinical trials.
 
In this project ODI is collaborating with:

“We received this grant in strong competition with Norwegian start-ups and university technology transfer offices. This is a great opportunity for us to continue development, demonstrate our concept and to strengthen our relationship with our fantastic collaborators.” states CEO Svein-Erik Måsøy.

 

ODI Medical
ODI Medical is developing technology for bedside measurement and quantification of circulatory failure based on assessment of microcirculation. Our concept, the Oxygen Delivery Index™, may be used for a wide range of clinical applications such as monitoring patients on mechanical heart and lung machines, evaluation of toxicity of chemotherapy, early detection of evolving sepsis; monitoring of chronic wounds, and mass screening of conditions such as Ebola, bird flu or endemic meningitis. ODI Medical is commercialising its concepts on the foundation of 30 years research from its founder, Professor Knut Kvernebo, from The Oslo University Hospital (OUS), Oslo, Norway.